Evidence map›Paper›PMID 20825389›Full record

ArticleBasic & clinical pharmacology & toxicology2011

Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.

Yan Chang, Wenfang B Fang, Shen-Nan Lin, David E Moody

Open access · bronzeAbstract read
In one paragraph

Article in Basic & clinical pharmacology & toxicology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 96 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Natural Products Inhibition of Cytochrome P450 2B6 Activity and Methadone Metabolism.Drug metabolism and disposition: the biological fate of chemicals · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Novel associations betweenPharmacogenomics · 2021
    Observational
  12. Article
  13. Review
  14. Article
  15. Article
  16. Effects ofFrontiers in public health · 2019
    Article
  17. Human Enzymes for Organic Synthesis.Angewandte Chemie (International ed. in English) · 2018
    Review
  18. Review
  19. Practical Pharmacology of Methadone: A Long-acting Opioid.Indian journal of palliative care · 2018
    Review
  20. Tell-Tale SNPs: The Role of CYP2B6 in Methadone Fatalities.Journal of analytical toxicology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yan ChangCenter for Human Toxicology, Department of Pharmacology and Toxicology, University of Utah, 417 Wakara Way, Salt Lake City, UT, USA.
Wenfang B Fang
Shen-Nan Lin
David E Moody
University of Utah · US

Funding

Human Metabolism of Anti-Abuse MedicationsR01DA010100 · NIDA · UNIVERSITY OF UTAH · PI MOODY, DAVID E · 1997 to 2005
$750k
NIDA NIH HHS R01 DA010100NIDA NIH HHS R01 DA10100
6 · The paper itself

Abstract

In vitro metabolism of methadone was investigated in cytochrome P450 (CYP) supersomes and phenotyped human liver microsomes (HLMs) to reconcile past findings on CYP involvement in stereo-selective metabolism of methadone. Racaemic methadone was used for incubations; (R)- and (S)-methadone turnover and (R)- and (S)-EDDP formation were determined using chiral liquid chromatography-tandem mass spectrometry. CYP supersome activity for methadone use and EDDP formation ranked CYP2B6 > 3A4 > 2C19 > 2D6 > 2C18, 3A7 > 2C8, 2C9, 3A5. After abundance scaling, CYP3A4, 2B6 and 2C19 accounted for 63-74, 12-32 and 1. 4-14% of respective activity. CYP2B6, 2D6 and 2C18 demonstrated a preference for (S)-EDDP formation; CYP2C19, 3A7 and 2C8 for (R)-EDDP; 3A4 none. Correlation analysis with 15 HLMs supported the involvement of CYP2B6 and 3A. The significant correlation of S/R ratio with CYP2B6 activity confirmed its stereo-selectivity. CYP2C19 and 2D6 inhibitors and monoclonal antibody (mAb) did not inhibit EDDP formation in HLM. Chemical and mAb inhibition of CYP3A in high 3A activity HLM reduced EDDP formation by 60-85%; inhibition of CYP2B6 in 2B6 high-activity HLM reduced (S)-EDDP formation by 80% and (R)-EDDP formation by 55%. Inhibition changed methadone metabolism in a stereo-selective manner. When CYP3A was inhibited, 2B6 mediated (S)-EDDP formation predominated; S/R stereo-selectivity increased. When 2B6 was inhibited (S)-EDDP formation fell and stereo-selectivity decreased. The results confirmed the primary roles of CYPs 3A4 and 2B6 in methadone metabolism; CYP2C8 and 2C9 did not appear involved; 2C19 and 2D6 have minimal roles. CYP2B6 is the primary determinant of stereo-selective metabolism; stereo-selective inhibition might play a role in varied plasma concentrations of the two enantiomers.

Indexed as

Analgesics, OpioidAryl Hydrocarbon HydroxylasesCytochrome P-450 CYP2B6Cytochrome P-450 CYP2C19Cytochrome P-450 CYP2D6Cytochrome P-450 CYP2D6 InhibitorsCytochrome P-450 CYP3ACytochrome P-450 CYP3A InhibitorsCytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemHumansMethadoneMicrosomes, LiverOxidoreductases, N-DemethylatingStereoisomerismAnalgesics, OpioidAryl Hydrocarbon HydroxylasesCYP2B6 protein, humanCYP2C19 protein, humanCYP3A4 protein, humanCytochrome P-450 CYP2B6Cytochrome P-450 CYP2C19Cytochrome P-450 CYP2D6Cytochrome P-450 CYP2D6 InhibitorsCytochrome P-450 CYP3ACytochrome P-450 CYP3A InhibitorsCytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemMethadoneOxidoreductases, N-Demethylating

Identifiers

PMID20825389
PMCPMC3005981
OpenAlexW1555210154

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.